Tokai Carbon (5301) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for Jan–Sep 2024 declined 3.4% YoY to ¥258.6 billion, operating income fell 48.9% to ¥15.2 billion, and net income dropped 73.9% to ¥5.6 billion.
EBITDA decreased to ¥46.7 billion (-17.8%), with the margin at 18.1% in the upper 10% range.
Comprehensive income dropped 77.4% YoY to ¥15.5 billion, reflecting challenging global conditions and segment underperformance.
Carbon Black and Fine Carbon segments grew, while Smelting & Lining and Graphite Electrodes saw sharp declines due to weak demand and competition.
Financial soundness and liquidity remain high, with stable credit ratings and investment capacity.
Financial highlights
Net sales: ¥258.6 billion (-3.4% YoY); Operating income: ¥15.2 billion (-48.9% YoY); Net income: ¥5.6 billion (-73.9% YoY).
EBITDA: ¥46.7 billion (-17.8% YoY); EBITDA margin: 18.1% (-3.2 pts YoY).
Gross profit: ¥61.1 billion (down YoY); EPS: ¥26.18 (prior year: ¥100.26).
Total assets: ¥651.1 billion as of Sep 30, 2024; equity ratio: 50.3%.
Return on sales: 5.9% (-5.2 pts YoY); net margin: 2.2% (prior year: 8.0%).
Outlook and guidance
Full-year 2024 forecast: Net sales ¥370 billion (+1.7% YoY), operating income ¥23 billion (-40.6%), ROS 6.2%, EBITDA ¥65 billion, net income ¥15 billion, EPS ¥70.35.
Annual dividend forecast unchanged at ¥30.00 per share.
Ongoing restructuring of graphite electrode production; impact on full-year results to be reflected upon finalization.
Latest events from Tokai Carbon
- Operating income surged 33.3% despite a 7.8% sales drop; net income returned to profit.5301
Q4 202513 Feb 2026 - Vision 2030 aims for ¥500B sales and 20% EBITDA margin, led by Fine Carbon and Industrial Furnaces.5301
Investor presentation13 Feb 2026 - Operating and net income surged despite lower sales, with an improved full-year outlook.5301
Q3 20257 Nov 2025 - Operating income surged 65.7% despite a 7.5% sales decline, reflecting successful reforms.5301
Q2 20258 Aug 2025 - Profits plunged and major restructuring in graphite electrodes marked a challenging H1 2024.5301
Q2 202413 Jun 2025 - Operating income more than doubled, offsetting lower sales and segment pressures.5301
Q1 20256 Jun 2025 - Net loss from extraordinary items in FY2024; recovery and reforms expected in FY2025.5301
Q4 20245 Jun 2025